Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Alese · SciRah

Researcher profile · Semantic Scholar

O. Alese

Share profile

O. Alese — researcher profile on SciRah

h-index: 32
Works: 255
Citations: 3,554

Most-cited papers

Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers.
O. Alese, N. Cook, A. Ortega-Franco, Mark B. Ulanja +2 more
2022American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting49 citations Open access
Semantic Scholar
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
J. Alvarez, Q. Shi, A. Dasari, J. Garcia-Aguilar +26 more
2024BMC Cancer40 citations Open access
Semantic Scholar
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer
M. Akce, Batoul Farran, Jeffrey M. Switchenko, M. Rupji +10 more
2023Journal for ImmunoTherapy of Cancer38 citations Open access
Semantic Scholar
Update on Emerging Therapies for Advanced Colorectal Cancer.
O. Alese, Christina Wu, W. Chapin, Mark B. Ulanja +3 more
2023American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting37 citations Open access
Semantic Scholar
Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine Carcinomas
M. Wermke, V. Gambardella, Y. Kuboki, E. Felip +11 more
2025Journal of Clinical Oncology36 citations Open access
Semantic Scholar
Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine
G. Nagaraju, M. Saddala, Jeremy B. Foote, A. Khaliq +16 more
2024Cell Reports Medicine27 citations Open access
Semantic Scholar
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
T. Cannon, M. Rothe, P. Mangat, E. Garrett-Mayer +20 more
2024Journal of Clinical Oncology15 citations
Semantic Scholar
Alliance A022104/NRG-GI010: A randomized phase II trial testing the efficacy of triplet versus doublet chemotherapy to achieve clinical complete response in patients with locally advanced rectal cancer—The Janus Rectal Cancer trial.
J. Smith, A. Dasari, Q. Shi, J. García-Aguilar +14 more
2023Journal of Clinical Oncology14 citations
Semantic Scholar
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma.
Tim Meyer, R. Finn, M. Borad, A. Mahipal +30 more
2025Journal of Hepatology11 citations Open access
Semantic Scholar
Survival trends for left and right sided colon cancer using population‐based SEER database: A forty‐five‐year analysis from 1975 to 2019
Mark B. Ulanja, K. Asafo-Agyei, Vijay Neelam, B. Beutler +9 more
2024Cancer Medicine11 citations Open access
Semantic Scholar
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
N. Rohatgi, M. Rothe, P. Mangat, E. Garrett-Mayer +19 more
2023JCO Precision Oncology11 citations
Semantic Scholar
Efficacy and safety of the DLL3/CD3 T-cell engager obrixtamig in patients with extrapulmonary neuroendocrine carcinomas with high or low DLL3 expression: Results from an ongoing phase I trial.
J. Capdevila, V. Gambardella, Y. Kuboki, O. Alese +10 more
2025Journal of Clinical Oncology10 citations
Semantic Scholar
Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer
O. Gbolahan, Xiaojie Zhi, Yuan Liu, M. Shah +2 more
2024JAMA Network Open10 citations Open access
Semantic Scholar
Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared to Pancreatic Ductal Adenocarcinoma
Lana E. Khalil, Zhonglu Huang, K. Zakka, Renjian Jiang +8 more
2023Pancreas10 citations Open access
Semantic Scholar
XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial
Maggie J. Phillips, O. Alese, Natalie K. Horvat, E. Greene +12 more
2025Oncoimmunology9 citations Open access
Semantic Scholar
Olaparib in Patients With Pancreatic Cancer With BRCA1/2 Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study
E.R. Ahn, M. Rothe, P. Mangat, E. Garrett-Mayer +16 more
2024JCO Precision Oncology9 citations Open access
Semantic Scholar
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
J. Alvarez, Q. Shi, A. Dasari, J. Garcia-Aguilar +22 more
2024medRxiv9 citations Open access
Semantic Scholar
Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
Sandra Kang, Lana E. Khalil, Ashley A. McCook-Veal, Yuan Liu +9 more
2023Liver Cancer International8 citations Open access
Semantic Scholar
Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
T. Albaghdadi, M. Rothe, P. Mangat, E. Garrett-Mayer +25 more
2025JCO Precision Oncology7 citations
Semantic Scholar
Perceptions and Needs for a Technology-Based Dyadic Intervention on Symptom Management Among Patients With Colorectal Cancer and Their Caregivers: A Qualitative Study.
Amruta Epari, Kevin Kim, Canhua Xiao, Laura S. Porter +5 more
2024Cancer Nursing6 citations
Semantic Scholar
Pertuzumab plus trastuzumab (P+T) in patients (pts) with biliary tract cancer (BTC) with ERBB2/3 amplification (amp), overexpression (oe), or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
T. Cannon, M. Rothe, E. Garrett-Mayer, V. Chiu +16 more
2023Journal of Clinical Oncology6 citations Open access
Semantic Scholar
Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence
O. S. Adekolujo, Ahsan Wahab, M. Akanbi, Tolutope Oyasiji +2 more
2023Cancer Biology & Therapy6 citations Open access
Semantic Scholar
A Web-Based Dyadic Intervention to Manage Psychoneurological Symptoms for Patients With Colorectal Cancer and Their Caregivers: Protocol for a Mixed Methods Study
Yu-Fen Lin, L. S. Porter, Wonshik Chee, O. Alese +4 more
2023JMIR Research Protocols6 citations Open access
Semantic Scholar
Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells
Munevver Cinar, L. Martínez-Medina, P. Puvvula, A. Arakelyan +18 more
2024Nucleic Acids Research5 citations Open access
Semantic Scholar
Abstract CT136: Phase Ib study of siltuximab and spartalizumab in advanced pancreatic cancer
O. Alese, O. Gbolahan, K. Coleman, Yichun Cao +12 more
2024Cancer Research5 citations
Semantic Scholar
Nipavect: Phase II study of niraparib and panitumumab in advanced RAS WT colorectal cancer.
O. Alese, M. Diab, O. Gbolahan, Ashley A. McCook-Veal +6 more
2023Journal of Clinical Oncology5 citations
Semantic Scholar
Utilizing Patient Input in Rectal Cancer Trial Design.
Janet Alvarez, W. Zambare, M. George, Reese Garcia +23 more
2025Journal of the National Cancer Institute4 citations Open access
Semantic Scholar
High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma
E. Greene, Natalie K. Horvat, D. Doxie, V. Parihar +16 more
2025Cancer Research4 citations Open access
Semantic Scholar
ATHENA: A phase 1/2 study of AZD5851, a chimeric antigen receptor (CAR) T-cell therapy directed against GPC3 in adult patients with advanced/recurrent hepatocellular carcinoma (HCC).
A. Hamilton, R. Kelley, Daneng Li, Ignacio Melero Bermejo +16 more
2024Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Phase 1/1b study of SY-5609, a selective and potent CDK7 inhibitor, in advanced solid tumors and in 2L/3L pancreatic ductal adenocarcinoma (PDAC) in combination with gemcitabine +/- nab-paclitaxel.
B. Bashir, Manish R Sharma, D. Juric, K. Papadopoulos +16 more
2023Journal of Clinical Oncology4 citations Open access
Semantic Scholar
A multi-cohort phase I/IIa clinical trial to evaluate the safety, tolerability, and pharmacokinetics of TST001 administered as a monotherapy, with nivolumab or standard of care in patients with locally advanced or metastatic solid tumors: TransStar101.
Y. Janjigian, Wei-Jing Sun, C. M. R. Rocha Lima, Satish Shah +16 more
2023Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Olaparib (O) in patients (pts) with colorectal cancer (CRC) with ATM mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
D. Behl, M. Rothe, P. Mangat, E. Garrett-Mayer +16 more
2023Journal of Clinical Oncology4 citations
Semantic Scholar
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
D. Carrizosa, M. Rothe, P. Mangat, E. Garrett-Mayer +27 more
2026JCO Precision Oncology3 citations
Semantic Scholar
Phase 1 study of HMPL-306, an inhibitor of mutant IDH1/IDH2 (mIDH1/2), in western patients (pts) with advanced mIDH solid tumor, including glioma.
Jordi Rodon Ahnert, J. M. Sepúlveda Sánchez, O. Alese, G. Anguera +14 more
2025Journal of Clinical Oncology3 citations
Semantic Scholar
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study
E. Borazanci, Nathan Bahary, Vincent Chung, Timothy K. Huyck +15 more
2024The Oncologist3 citations Open access
Semantic Scholar
A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.
R. Yaeger, Q. Shi, A. Dueck, E. Dib +7 more
2023Journal of Clinical Oncology3 citations
Semantic Scholar
Nivolumab plus ipilimumab (N+I) in patients (pts) with ovarian cancer (OC) with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
C. Drescher, M. Rothe, P. Mangat, E. Garrett-Mayer +13 more
2023Journal of Clinical Oncology3 citations
Semantic Scholar
Changes in Prescribing Patterns in Stage III Colon Cancer.
F. Ou, D. Walden, J. Larson, Sandra Kang +10 more
2023The Journal of the National Comprehensive Cancer Network3 citations Open access
Semantic Scholar
The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers
A. Draper, Emily H. Jung, Yichun Cao, Rami Atallah +6 more
2023Oncology3 citations
Semantic Scholar
Abstract LB-A003: Efficacy and safety of the DLL3/CD3 T-cell engager obrixtamig in patients with extrapulmonary neuroendocrine carcinomas with high or low DLL3 expression: results from an ongoing Phase I trial
J. Capdevila, V. Gambardella, Y. Kuboki, O. Alese +11 more
2026Cancer immunology research2 citations
Semantic Scholar
Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancer
O. Alese, R. D. Harvey, Christina S. Wu, E. Hitron +8 more
2025The Oncologist2 citations Open access
Semantic Scholar
Tetravalent death receptor 5 (DR5) agonist ozekibart (INBRX-109) + FOLFIRI in 2L+ colorectal adenocarcinoma (CRC): Preliminary results from a phase 1 study.
D. Berz, O. Alese, D. Hong, N. Lakhani +9 more
2025Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Top advances of the year: Reappraisal of systemic versus local therapy for hepatocellular carcinoma
M. Oyenuga, Tia McGrew, L. Hannan, O. Alese
2025Cancer2 citations
Semantic Scholar
The Evolving Role of Immunotherapy for Gastroesophageal Malignancies
O. Emiloju, Ruo-Yu Miao, O. Alese
2025Annals of Surgical Oncology2 citations
Semantic Scholar
A Phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling
Natalie K. Horvat, Maria Diab, Maggie J. Phillips, Ashley Veal-McCook +13 more
2025Cancer Letters2 citations Open access
Semantic Scholar
Lenvatinib in recurrent hepatocellular carcinoma after liver transplantation.
M. Akce, O. Gbolahan, Jeffrey M. Switchenko, M. Sonbol +6 more
2024Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Development of a Technology-Based Dyadic Intervention for Underserved Colorectal Cancer Patients and Caregivers
Yu-Fen Lin, Canhua Xiao, Laura S. Porter, O. Alese +4 more
2024Nursing Informatics2 citations Open access
Semantic Scholar
A pilot study of the immune microenvironment of GI neuroendocrine carcinoma.
Andrew McDonald, V. Avadhani, G. Oprea-Ilies, K. Zakka +3 more
2024Endocrine-Related Cancer2 citations
Semantic Scholar
The impact of COVID‐19 on mortality, length of stay, and cost of care among patients with gastrointestinal malignancies: A propensity score‐matched analysis
Mark B. Ulanja, B. Beutler, K. Asafo-Agyei, Samuel B. Governor +10 more
2023Cancer Medicine2 citations Open access
Semantic Scholar
A phase 1, first-in-human (FIH), dose-escalation and dose-optimization study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 T-cell engager in participants with advanced or metastatic microsatellite-stable (MSS)/microsatellite instability–low (MSI-L) color
A. Spira, D. Sommerhalder, Annie Winterhall, T. Buchholz +11 more
2026Journal of Clinical Oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Akce×8
Invite
M. Akce — researcher profile on SciRah
M. Rothe×8
Invite
M. Rothe — researcher profile on SciRah
G. N. Grantham×8
Invite
G. N. Grantham — researcher profile on SciRah
R. Schilsky×8
Invite
R. Schilsky — researcher profile on SciRah

×8

Invite

O. Gbolahan — researcher profile on SciRah

Jeffrey M. Switchenko×7

Invite

Jeffrey M. Switchenko — researcher profile on SciRah

Invite

P. Mangat — researcher profile on SciRah

T. Albaghdadi×6

Invite

T. Albaghdadi — researcher profile on SciRah

Invite

R. Thota — researcher profile on SciRah

Invite

D. Hinshaw — researcher profile on SciRah

Invite

A. Gregory — researcher profile on SciRah

Invite

A. Shergill — researcher profile on SciRah